Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Manufacturing
CSL Seqirus picks up its 5th bird-flu-related BARDA award
With a $121.4 million award, the vaccine maker will make enough adjuvant for 40 million vaccine doses.
Zoey Becker
Sep 26, 2024 3:50pm
Bavarian Nordic locks up $157M Jynneos supply pact with US
Aug 8, 2024 9:09am
BARDA signs on with CSL Seqirus for 4.8M bird flu shots
May 30, 2024 2:32pm
FDA OKs Basilea's antibiotic Zevtera for 3 types of infections
Apr 4, 2024 8:45am
Venatorx, Melinta's antibiotic rejected over manufacturing issues
Feb 23, 2024 10:55am
Gritstone's BARDA-funded COVID vaccine hit with delay
Feb 12, 2024 1:10pm
